Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent

References

• Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. 2010. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding. Colloids Surf B. 81:96–109.
   PubMed Web of Science ®Google Scholar
• Beck C, Dalvi SV, Dave RN. 2010. Controlled liquid antisolvent precipitation using a rapid mixing device. Chem Eng Sci. 65:5669–5675.
   Web of Science ®Google Scholar
• Berkovitch-Yellin Z. 1985. Towards an abinitio derivation of crystal morphology. J Amer Chem Soc. 107:8239–8253.
   Web of Science ®Google Scholar
• Bhadra S, Kumar M, Jain S, Agrawal S, Agrawal GP. 2004. Spherical crystallization of mefenamic acid. Pharm Tech. 28:66–76.
   Google Scholar
• Blandin AF, Mangin D, Rivoire A, Kelin JP, Bossoutrot JM. 2003. Agglomeration in suspension of salicylic acid fine particles: influence of some process parameters on kinetics and agglomerates final size. Powder Technol. 130:316–323.
   Web of Science ®Google Scholar
• Capes C, Fouda A. 1984. Agglomeration in liquid systems. In: Fayed ME, Otten LP, editors. Handbook of powder science and technology. New York: VanNostrand Reinhold; p. 331–344.
   Google Scholar
• Carr RL. 1965a. Classifying flow properties of solids. Chem Eng. 72:69–72.
   Google Scholar
• Carr RL. 1965b. Evaluation flow properties of solids. Chem Eng. 72:163–168.
   Google Scholar
• Chawla G, Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. 2003. Characterization of solid-state forms of celecoxib. Eur J Pharm Sci. 20:305–317.
   PubMed Web of Science ®Google Scholar
• Davey RJ. 1982. Solvent effects in crystallization processes. In: Kaldis E, editor. Current topics in materials science. Amsterdam: North-Holland; p. 429–479.
   Google Scholar
• Di Martino P, Di Cristofaro R, Barthélémy C, Joiris E, Palmieri FG, Sante M. 2000. Improved compression properties of propyphenazone spherical crystals. Int J Pharm. 197:95–106.
   PubMed Web of Science ®Google Scholar
• Fiese EF, Hagen TA. 1986. Preformulation. In: Lachman L, Lieberman HA, Kanig JL, editors. Theory and practice of industrial pharmacy. 3rd ed. Philadelphia: Lea and Febiger; p. 171–196.
   Google Scholar
• Fouad EA, El-Badry M, Mahrous GM, Alanazi FK, Neau SH, Alsarra IA. 2011. The use of spray-drying to enhance celecoxib solubility. Drug Dev Ind Pharm. 37:1463–1472.
   PubMed Web of Science ®Google Scholar
• George M, Ghosh I. 2013. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Euro J Pharm Sci. 48:142–152.
   PubMed Web of Science ®Google Scholar
• Gohle MC, Parikh RK, Shen H, Rubey RR. 2003. Improvement in flowability and compressibility of AmpicillineTrihydrate by spherical crystallization. Ind J Pharm Sci. 65:634–637.
   Google Scholar
• Gupta VR, Mutalik S, Patel MM, Jani GK. 2007. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm. 57:173–184.
   PubMedGoogle Scholar
• Homayouni A, Sadeghi F, Varshosaz J, AfrasiabiGarekani H, Nokhodchi A. 2014. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J Pharm Biopharm. 88:261–274.
   PubMed Web of Science ®Google Scholar
• Horn D, Rieger J. 2001. Organic nanoparticles in the aqueous phase-theory, experiment, and use. Angew Chem Int Ed Engl. 40:4330–4361.
   PubMed Web of Science ®Google Scholar
• Horter D, Dressman JB. 2001. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal trac. Adv Drug Deliv Rev. 46:75–87.
   PubMed Web of Science ®Google Scholar
• Jbilou M, Ettabia A, Guyot-Hermann AM, Guyot JC. 1999. Ibuprofen agglomerates preparation by phase separation. Drug Dev Ind Pharm. 25:297–305.
   PubMed Web of Science ®Google Scholar
• Kachrimanis K, Ktistis G, Malamataris S. 1998. Crystallization conditions and physicochemical properties of ibuprofen-Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique. Int J Pharm. 173:61–74.
   Web of Science ®Google Scholar
• Kawashima Y. 1994. New process-application of spherical crystallization to particulate design of pharmaceuticals for direct tabletting and coating.and new drug delivery systems. In: Chulia D, Deleuil M, Pourcelot Y, editors. Powder technology and pharmaceutical processes. New York: Elsevier; p. 493–512.
   Google Scholar
• Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. 1994. Improvement in flowability and compressibility of pharmaceutical crystals for direct tableting by spherical crystallization with a two solvent system. Powder Technol. 78:151–157.
   Web of Science ®Google Scholar
• Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. 2003. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 130:283–289.
   Web of Science ®Google Scholar
• Kawashima Y, Okumura M, Takenaka H. 1982. Spherical crystallization: direct spherical agglomeration of salicylic acid crystals during crystallization. Science. 216:1127–1128.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Okumura M, Takenaka H. 1984. The effects of temperature on the spherical crystallization of salicylic acid. Powder Technol. 39:41–47.
   Web of Science ®Google Scholar
• Labouret A, Thioune O, Fessi H, Devissaguet JP. 1995. PuisieuxF. Application of an original process for obtaining colloidal dispersions of some coating polymers. Preparation, characterization, industrial scaling up. Drug Dev Ind Pharm. 21:229–241.
   Web of Science ®Google Scholar
• Maghsoodi M, Barghi L. 2011. Design of agglomerated crystals of ibuprofen during crystallization: influence of surfactant. IJBMS. 14:161–169.
   Google Scholar
• Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M, Nokhodchi A, Martin G. 2007. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique. Drug Dev Ind Pharm. 33:1216–1224.
   PubMed Web of Science ®Google Scholar
• Maghsoodi M, TajalliBakhsh A. 2011. Evaluation of physicomechanical properties of drug-excipients agglomerates obtained by crystallization. Pharm DevTechnol. 16:243–249.
   PubMed Web of Science ®Google Scholar
• Merck & Co., Inc. 2000. The Merck Index. Rahway, NJ: Merck & Co., Inc.
   Google Scholar
• Mersmann A. 1999. Crystallization and precipitation. 1. ChemEng Process. 38:345–353.
   Web of Science ®Google Scholar
• Paradkar AR, Pawar AP, Chordiya JK. 2002. Spherical crystallization of celecoxib. Drug Dev Ind Pharm. 28:1213–1220.
   PubMed Web of Science ®Google Scholar
• Puechagut HG, Bianchotti J, Chaile CA. 1998. Preparation of norfloxacin spherical agglomerates using the ammonia diffusion system. J Pharm Sci. 87:519–523.
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Tamayo-Esquivel D, Ganem-Quintanar A, Allémann E, Doelker E. 2005. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidicnanospheres. Euro J Pharm Sci. 26:211–218.
   PubMed Web of Science ®Google Scholar
• Shekunov BY, York P. 2000. Crystallization processes in pharmaceutical technology and drug delivery design. J Crystal Growth. 211:122–136.
   Web of Science ®Google Scholar
• Shen SC, Ng WK, Chia L, Hu J, Tan RB. 2011. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm. 410:188–195.
   PubMed Web of Science ®Google Scholar
• Slavtchev S, Kalitzova-Kurteva P, Mendes MA. 2006. Marangoni instability of liquid–liquid systems with a surface-active solute. Colloid Surf. 282:37–49.
   Web of Science ®Google Scholar
• Staniforth J. 2002. Powder flow. In: Aulton ME, editor. Pharmaceutics. 2nd ed. London: Churchill Livingstone; p. 207–428.
   Google Scholar
• Subero-Couroyer C, Mangin D, Rivoire A, Blandin AF, Kelin JP. 2005. Agglomeration in suspension of salicylic acid fine particles: analysis of the wetting period and effect of the binder injection mode on the final agglomerate size. Powder Technol. 161:98–109.
   Web of Science ®Google Scholar
• Teychené S, Sicre N, Biscans B. 2010. Is spherical crystallization without additive possible. Chem Eng Res Des. 88:1631–1638.
   Web of Science ®Google Scholar
• USP/NF. 2007. Powder flow <1174>, United State Pharmacopeial Convention. Rockville (MD): The United State Pharmacopeia30/National Formulary25.
   Google Scholar
• Wehrle P, Magenheim B, Benita S. 1995. The influence of processparameters on PLA nanoparticles size distribution, evaluated by factorial design. Eur J Pharm Biopharm. 41:19–26.
   Web of Science ®Google Scholar